Meningococcal Vaccines Market Insight, Regional & Segmental Share Analysis | Forecast – 2025

1. Meningococcal Vaccines Market Global Industry Insight, Sizing, Share Analysis, Growth, Trend | Forecast to 2025 PREPARED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)

2. Meningococcal Vaccines Market Meningococcal Vaccines Market – Overview Various factors are adding to the global meningococcal vaccines market share. These factors include a rise in healthcare spending, an increase in research and development for these vaccines, growing interventions by the government associated with meningococcal vaccines, presence of different government awareness programs, and manufacturing of meningococcal vaccines at budget-friendly prices. Despite broad and effective commitment from the global health community in meningitis A (MENA) vaccination in the meningitis belt, low manufacturing capacity and high prices across other meningococcal vaccine types have hindered access to these vaccines over the past several years. A more in-depth knowledge will benefit addressing these long-standing access issues and the development of the WHO global roadmap for overcoming meningitis by 2030. This is expected to set goals for disease control and vaccination for meningococcal meningitis on a global level. Global meningococcal vaccines market has a demand for about USD 172 million doses in 2019, while the estimated supply is likely to be 203 million doses. Meningococcal vaccines are vaccines used for preventing infection caused by Neisseria meningitidis. Subcapsular vaccine, polysaccharide, and meningococcal conjugate vaccine are the different types of vaccines effective against all or some of these meningococcus types- A, B, C, Y, and W-135. www.marketresearchfuture.com

3. Meningococcal Vaccines Market Meningococcal Vaccines Market Segmentation The Market Research Future Report provides an inclusive segmental analysis of the global meningococcal vaccines market based on end user and treatment type. Based on the treatment, the global product market can be divided into polysaccharide, meningococcal A conjugate vaccine, and subcapsular vaccine. The meningococcal conjugate vaccine is mostly used in mass campaigns in affected regions of Africa. Since 2010, the demand for such vaccines has been uncertain, based on the national immunization programs that are being adopted based on the country’s effectiveness and readiness to tackle the disease. Moreover, the demand and supply for SubcapMenB vaccines is a desirable combination that will moderate the global product scenario. By the end-user, the global vaccine market can be split into research laboratories, hospital and clinical, and academic institutes. The hospitals and clinics segment holds major share in the global market for meningococcal vaccines. Get Free Sample of Report @ https://www.marketresearchfuture.com/sample_request/8622 www.marketresearchfuture.com

4. Meningococcal Vaccines Market Meningococcal Vaccines Market – Regional Analysis Based on the region, the global meningococcal vaccines market report covers the recent trends and growth opportunities across Europe, North America, the Asia Pacific (APAC), and the Middle East and Africa (MEA). North America will lead the market over the forecast period. Factors propelling the market growth include an increase in disease outbreaks, easy availability of products, increasing awareness about the disease, rapid adoption of advanced products, and increasing penetration of new entrants with new technology. The US is the key contributor in the region as it is a leading innovation hub where the leading companies from worldwide conduct R&D activities. Europe is predicted to have a healthy growth over the forecast period followed by the APAC region, which is predicted to grow at a fast pace for the increasing awareness about the disease, improving access to the healthcare system, and the presence of a huge population. During 2016-2018, UNICEF introduced the meningococcal conjugate vaccine in 26 countries and Ghana was the first country in Africa to receive this vaccination. Currently, the meningococcal vaccine has reached across different regions, in the most remote locations, and has increased in demand and supply in the global market. Browse Report @ https://www.marketresearchfuture.com/reports/meningococcal-vaccines-market-8622 www.marketresearchfuture.com

5. Meningococcal Vaccines Market Meningococcal Vaccines Market Competitive Analysis Industry players have incorporated strategies such as mergers & acquisitions, geographical expansions, strategic alliances, contracts, new product development, joint ventures, and collaborations to stay ahead in the competition and also cater to the burgeoning needs of customers. Notable players profiled in the global meningococcal vaccines market report include GlaxoSmithKline, Serum Institute of India Ltd., Biomed Pvt. Ltd., JN-International Medical Corporation, Sanofi S.A., Novartis Pharmaceuticals Canada Inc, Pfizer Inc., and Baxter International, among others. In 2018, Pfizer granted FDA Breakthrough Therapy designation for Trumenba (Meningococcal Group B Vaccine). This vaccine plays a major role in the prevention of invasive meningococcal B disease in children aged 1 to 9 years. In 2018, GSK’s (GlaxoSmithKline) meningitis B vaccine Bexsero received breakthrough therapy designation from the US FDA for prevention of Invasive Meningococcal Disease for children 2-10 years of age. Ask Questions To The Experts @ https://www.marketresearchfuture.com/enquiry/8622 www.marketresearchfuture.com

6. ABOUT US MARKET RESEARCH FUTURE At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit www.marketresearchfuture.com or contact us at info@marketresearchfuture.com Copyright © 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future. www.marketresearchfuture.com

7. MARKET RESEARCH FUTURE THANK YOU sales@marketresearchfuture.com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK) www.marketresearchfuture.com